Four of the present "pure" opiate antagonists, naloxone, naltrexone, nalbuphine and nalmexone all have in common the feature of a hydroxyl-group in the position 14 (Blumberg and Dayton, 1974) . Thus the OH-group seems to be responsible for the pure antagonistic effect and for the absence of dysphoria, which often is noted after the administration of other opiate antagonists such as nalorphine and cyclazocine (Lasagna and Beecher, 1954; Houde and Wallenstein, 1955; Keats and Telford, 1957) .
All four oxymorphone-derivatives, however, are characterized by a short duration of action. Fentanyl, which accumulates in the so-called silent receptor sites-the proteins of the blood, the lung, the liver, the heart, the muscle mass, the skin and the fat-tissue (Hess, Herz and Friedel, 1971 )-may be released into the blood stream in the period late after operation (redistribution). Thus any increase in plasma fentanyl concentration induces a rapid transfer of the opiate through the blood-brain barrier occupying opiate receptor sites in the area postrema (Pen and Snyder, 1973) , followed by respiratory depression.
For example 60 min after the injection of an initial dose of fentanyl 0.5 mg in man, 65% of the dose may be found in the silent receptor sites (Heykants, 1977) . From this depot (the peripheral compart-ment) local pH-changes induce a release of the drug which is followed by respiratory depression, a fact which has been labelled as "remorphinization" (Adams and Pybus, 1978; Ainslie, Eisele and Corkill, 1979) . Opiate antagonists which are able to block the opiate receptor sites over a long period of time would be suitable to prevent such a late effect.
Since naloxone, because of its oxygen bridge ( fig.  1 ), is considered to be rapidly metabolized in the liver, compounds which lack this bridge might have a longer duration of action (Pachter, 1974) . Two such substances are cyclorphan and oxilorphan. When oxygen is substituted in position 6 (the 6-oxoanalogue of oxilorphan: L-3, 14-dihydroxy-6-oxo-N-cyclopropyl-methyl-morphinan) ( fig. 1) , the compound shows an interesting pharmacological profile. Its potency in reversing morphine-induced analgesia is 2.5 times that of naloxone (Hirose et al., 1979) . This analogue of oxilorphane was compared with naloxone and its N-cyclopropyl-methyl derivative naltrexone ( fig. 1 ) in counteracting fentanylinduced respiratory depression in the dog. and 5, 30, 60, 120, 180 and 240 min after the injection of the antagonist:
(1) Respiratory rate, as measured by a change of impedance over the thoracic cage during respiratory movement of the animal (American Optical respiratory rate monitor).
(2) arterial blood-gases (/fcCh, Fo 2 ) measured from blood samples drawn from an exteriorized common carotid loop artery (Instrumentation Laboratory System 1303 Lexington, USA). Since any change in respiration is often accompanied by a change in the level of consciousness when opiates have been given, the EEG bipolar frontal activity (position C 2 -C 3 ) was detected, by silver/silver chloride stick-on electrodes, and amplified by an EEG-Schwarzer recorder (time constant 0.3, cut off frequency 30 Hz).
The values of each group were compared with the control as the percent change of each variable. For a given time the groups were compared among each other, calculating the statistical significance (Wilcoxon Rank, two-tailed probability). Significance was defined as P equal to or less than 0.05. Figure 2 shows the change in respiratory rate after the administration of fentanyl, followed by the three different opiate antagonists. Compared with the awake control with a respiratory rate of 49 + 2 (mean±SEM) b.p.m., fentanyl induces a decrease to 6 ± 1 b.p.m. (-85%). This depression was rapidly reversed by the opiate antagonist naloxone and by naltrexone, resulting in an overshoot reaction with a rate of 93 ± 22 and 88 ± 23 b.p.m. respectively. This antagonistic effect, however, was of short duration; 60 min after injection, the naloxone-group had a reduced respiratory rate of 14 ±3 b.p.m. (70% depression), an effect which was most obvious for naloxone and for naltrexone at 240 min (8+1 and 12 ± 8 b.p.m. respectively).
RESULTS
Compared with the two oxymorphonederivatives, S-20682 had a maximum action at 20-30min, with a respiratory rate of 43 ±8 b.p.m. and no overshoot. At 240 min the respiratory rate in the S-20682-group was 28 ±5, 40% less than control, while both the naloxone and the naltrexonegroup exhibited a depression by 85% and 78% respectively. The differences in the latter groups are statistically significant when compared with the S-20682 group.
This difference of action of the three antagonists is even more obvious when the increase in Pacc^ is compared in the three groups ( fig. 3 ). Hypercapnia with a mean value of 6.6±0.3kPa shortly after fentanyl (+30%) are rapidly reversed by naloxone and naltrexone. However, 60 min after antagonist injection, PacO2 increased significantly in the naloxone group (+11%) and in the naltrexone-group (+ 17%). This effect increased at 180 and 240 min after injection. At about 240 min the naloxone group showed an increase in PCCh (+33%) while the naltrexone group showed an increase (28%). Compared with these two compounds, S-20682 exhibited no immediate reversal of the fentanyl-induced hypercapnia. The maximum effect of S-20682 was at about 25-30 min when compared with control Pacc>2 (+3%). At 240min PacOj did not exceed 5.2kPa, significantly less when compared with the PCO2 values in the naloxone and naltrexone groups (6.8 and 6.1 kPa respectively).
In respect of changes in Pao2, naltrexone had a longer duration than did naloxone, the former inducing an antagonistic effect up to 60 min after injection ( fig. 4) . this effect decreased at 180 min when Po 2 was less than 11.9±0.5kPa. Only S-20682 demonstrated a long-lasting effect (fig. 4) . Figure 5 shows that, compared with the awake state with a dominant e.e.g. pattern in the beta band (high frequency of at least 18 Hz and low amplitudes), fentanyl induced a sleep-like pattern in the delta band, showing a low frequency with 0.5-2 Hz and high amplitudes. Such a pattern was reversed by all three antagonists. At 240 min the cortical activity of animals receiving S-20682 reveals a pattern similar to the awake state-activity with a maximum in the low alpha band (13-15 Hz). The other two groups present dominant low frequency, high amplitude waves again.
DISCUSSION
Redistribution of fentanyl causes a late (240 min) respiratory depression (McQuay etal, 1979; Stoeckel, Hengstmann and Schiittler, 1979) . Naloxone has a short duration of action which results in remorphinization and secondary respiratory depression up to 3 h after injection. Similar effects of remorphinization accompanied by respiratory depression have been observed in man (Longnecker, Pia Grazis and Eggers, 1973; Evans et al., 1974; Heisterkamp and Cohen, 1974) . Compared with naloxone the duration of action of the N-cyclo-propylmethyl analogue of oxymorphone, naltrexone, is twice as long in preventing fentanyl-induced respiratory depression. However, at 240 min after naltrexone, respiratory rate and PacOi reflect a reduction of respiratory drive. Only the 6-oxo analogue of oxilorphan, S-20682, was effective in minimising the respiratory effects of fentanyl at 240 min. The cause for such a long duration of action may be the lack of an oxygen bridge, which makes the molecule less susceptible to biological degradation (Pachter, 1974) . Additionally, S-20682 did not induce an "overshootreaction"-naloxone and even naltrexone were characterized by tachypnoea and hypocarbia.
A close interplay between cortical activity and respiratory function may be shown by the fact that respiratory depression was accompanied by slow and high amplitude waves in the EEG. This observation suggests that, in the case of opioid-induced respiratory depression, alertness is regularly depressed. 
PREVENTION DE LA DEPRESSION RESPIRATOIRE TARDIVE INDUITE PAR LE FENTANYL APRES L'INJECTION DE

SUMAJUO
Se llevaron a cabo ensayos con dot agentei opiaceos antagonisticoi (naltrexona y S-20682) comparados con la naloxona, en un perro intacto con el objeto de invertir la depresion resipiratoria inducida por K>M8k8~' dc fentanilo i.v. Se hideron mcdidones de la f recuencia de respiradon y de los gues-sangre arterial a los 5, 30, 60, 120, 180 y 240min despues de una inyecd6n i.v. adicionaldeagenteantagonistico(l ngkg" 1 )-Sin embargo, solo el S-20682, pero no asi la naloxona ni tampoco la naltrexona, previno la depresi6n tardia (240 min) del impulso retpiratorio, inducida por el fentanilo. Una depresi6n respiratoria tardia coinddia con un aumento de las amplitudes y una reducci6n de la frecuencia de la actividad cortical electrica (EEG). La naltrexona demostro tener un efecto antagonistico de una duraci6n doble (60 min) de la del efecto de la naloxona.
